Investigating RAB2A as a biomarker in the treatment of triple-negative breast cancer

Original language	English
Publication status	Published - 30 Mar 2022
Event	58th Irish Association for Cancer Research Conference 2022 - Radisson Blu Hotel, Cork, Ireland Duration: 30 Mar 2022 → 01 Apr 2022 https://www.iacr.ie/58-iacr-annual-conference/

Conference

Conference	58th Irish Association for Cancer Research Conference 2022
Abbreviated title	IACR 2022
Country/Territory	Ireland
City	Cork
Period	30/03/2022 → 01/04/2022
Internet address	https://www.iacr.ie/58-iacr-annual-conference/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 

Student theses

• Identification of E-cadherin and Rab2a as novel biomarkers to guide tailored treatment for triple-negative breast cancer

  Gao, L. (Author), Buckley, N. (Supervisor) & Furlong, F. (Supervisor), Jul 2024

  Student thesis: Masters Thesis › Master of Philosophy

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Gao, L. (2022). Investigating RAB2A as a biomarker in the treatment of triple-negative breast cancer. Poster session presented at 58th Irish Association for Cancer Research Conference 2022, Cork, Ireland.

Gao, Linbo. / Investigating RAB2A as a biomarker in the treatment of triple-negative breast cancer. Poster session presented at 58th Irish Association for Cancer Research Conference 2022, Cork, Ireland.

@conference{ee9b9335eb844ad7a73f2bd4883b2886,

title = "Investigating RAB2A as a biomarker in the treatment of triple-negative breast cancer",

author = "Linbo Gao",

year = "2022",

month = mar,

day = "30",

language = "English",

note = "58th Irish Association for Cancer Research Conference 2022, IACR 2022 ; Conference date: 30-03-2022 Through 01-04-2022",

url = "https://www.iacr.ie/58-iacr-annual-conference/",

}

Gao, L 2022, 'Investigating RAB2A as a biomarker in the treatment of triple-negative breast cancer', 58th Irish Association for Cancer Research Conference 2022, Cork, Ireland, 30/03/2022 - 01/04/2022.

Investigating RAB2A as a biomarker in the treatment of triple-negative breast cancer. / Gao, Linbo.
2022. Poster session presented at 58th Irish Association for Cancer Research Conference 2022, Cork, Ireland.

Research output: Contribution to conference › Poster

TY - CONF

T1 - Investigating RAB2A as a biomarker in the treatment of triple-negative breast cancer

AU - Gao, Linbo

PY - 2022/3/30

Y1 - 2022/3/30

M3 - Poster

T2 - 58th Irish Association for Cancer Research Conference 2022

Y2 - 30 March 2022 through 1 April 2022

ER -

Gao L. Investigating RAB2A as a biomarker in the treatment of triple-negative breast cancer. 2022. Poster session presented at 58th Irish Association for Cancer Research Conference 2022, Cork, Ireland.